![]() NanoString NS Wind Down (formerly NanoString Technologies) is a provider of life science tools for translational research and molecular diagnostics. | ![]() Viapath Viapath provides pathology and testing its partners, and NHS and private sector organizations. | ![]() 10X Genomics 10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience. | |
Founding Date | Founding Date 2003 | Founding Date 2009 | Founding Date 2012 |
Type | Type Subsidiary | Type Private | Type Public |
Tags | |||
Locations | Locations Seattle, US HQ Amsterdam, NL | Locations Bedford, GB HQ London, GB London, GB London, GB London, GB Orpington, GB | Locations Pleasanton, US HQ Shanghai, CN Leiden, NL Singapore, SG San Francisco, US |
Employees | Employees 7038% decrease | Employees 2701% decrease | Employees 1,17810% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $127.3m (FY, 2022) | Revenue (est.) £122m (FY, 2018) | Revenue (est.) $642.8m (FY, 2025) |
Cost of goods | Cost of goods $65.5m (FY, 2022) | Cost of goods £88.9m (FY, 2018) | Cost of goods $198.9m (FY, 2025) |
Gross profit | Gross profit $61.8m (FY, 2022) | Gross profit £33.1m (FY, 2018) | Gross profit $443.9m (FY, 2025) |
Net income | Net income ($159.5m) (FY, 2022) | Net income £2.5m (FY, 2018) | Net income ($43.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 152m | Total funding raised N/A | Total funding raised $ 195.5m |

Viapath provides pathology and testing its partners, and NHS and private sector organizations.
View company
10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience.
View company